Major Investor Group Reduces Stake in Bolt Biotherapeutics

summarizeSummary

A group of institutional investors, including Nan Fung Group and Pivotal bioVenture Partners, reported selling approximately $151,515 worth of Bolt Biotherapeutics common stock, reducing their collective ownership.

check_boxKey Events

• Investor Group Sells Shares

  A group of institutional investors, including Nan Fung Group and Pivotal bioVenture Partners, sold 24,801 shares of common stock.

• Significant Transaction Value

  The total value of the shares sold amounted to approximately $151,515.

• Reduced Ownership

  The sales occurred between January 28, 2026, and February 13, 2026, leading to a reduction in the group's overall percentage ownership.

auto_awesomeAnalysis

This Schedule 13D/A filing indicates that a significant investor group, comprising Nan Fung Group Holdings Limited, Pivotal bioVenture Partners Fund I, L.P., and related entities, has reduced its stake in Bolt Biotherapeutics. The group collectively sold 24,801 shares for a total value of approximately $151,515 between January 28, 2026, and February 13, 2026. While the absolute dollar value is modest, it represents a notable percentage of the company's small market capitalization. The sales occurred at prices ranging from $4.96 to $6.85 per share. This reduction in ownership by a major institutional holder could signal a shift in their investment thesis or a move to rebalance their portfolio.